Could Polyphenols Really Be a Good Radioprotective Strategy?

Area of Science:

• Oncology
• Radiotherapy
• Pharmacology

Background:

• Radiotherapy is a key cancer treatment, but normal tissue toxicity necessitates protective strategies.
• Reactive oxygen and nitrogen species increase radiation cytotoxicity, highlighting the need for scavengers or antioxidant enzyme enhancers.
• Plant-derived polyphenols offer potential as radioprotective agents due to their antioxidant properties.

Purpose of the Study:

• To review current scientific knowledge on polyphenols as radiomodulating agents.
• To assess the evidence for polyphenols in pure forms or plant extracts for radioprotection.
• To identify gaps in research regarding polyphenol efficacy in cancer therapy.

Main Methods:

• Literature review of in vitro, preclinical, and clinical studies on polyphenols and radiomodulation.
• Analysis of studies investigating antioxidant and pro-oxidant effects of polyphenols.
• Evaluation of research methodologies, including standardization and reproducibility.

Main Results:

• Polyphenols exhibit dose-dependent antioxidant/pro-oxidant activity, potentially protecting normal tissues selectively.
• Most available data on polyphenols' radiomodulating action derive from in vitro studies.
• Preclinical and clinical evidence supporting polyphenol efficacy remains limited and often lacks standardization.

Conclusions:

• Polyphenols are promising candidates for radioprotective applications in cancer treatment.
• Further robust preclinical and clinical studies are essential to validate their therapeutic potential.
• Standardization of plant extracts and chemical composition analysis are crucial for reproducible research.